Literature DB >> 20107618

High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Harald Mischak1, Bruce A Julian, Jan Novak.   

Abstract

All organisms contain thousands of proteins and peptides in their body fluids. A deeper insight into the functional relevance of these polypeptides under different physiological and pathophysiological conditions and the discovery of specific peptide biomarkers would greatly enhance diagnosis and therapy of specific diseases. The low-molecular-weight proteome, also termed peptidome, provides a rich source of information. Due to its unique features, the technical challenges differ somewhat from those in "common" proteomics. In this manuscript, we focus on the low-molecular-weight urinary proteome. We review the methodological aspects of sample collection, preparation, analysis, and subsequent data evaluation. In the second part of this review, we summarize the recent progress in the definition and identification of clinically relevant polypeptide markers.

Year:  2007        PMID: 20107618      PMCID: PMC2811330          DOI: 10.1002/prca.200700043

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  104 in total

1.  Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest.

Authors:  C S Spahr; M T Davis; M D McGinley; J H Robinson; E J Bures; J Beierle; J Mort; P L Courchesne; K Chen; R C Wahl; W Yu; R Luethy; S D Patterson
Journal:  Proteomics       Date:  2001-01       Impact factor: 3.984

2.  Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. II. Limitations of complex mixture analyses.

Authors:  M T Davis; C S Spahr; M D McGinley; J H Robinson; E J Bures; J Beierle; J Mort; W Yu; R Luethy; S D Patterson
Journal:  Proteomics       Date:  2001-01       Impact factor: 3.984

Review 3.  Methods for fractionation, separation and profiling of proteins and peptides.

Authors:  Haleem J Issaq; Thomas P Conrads; George M Janini; Timothy D Veenstra
Journal:  Electrophoresis       Date:  2002-09       Impact factor: 3.535

4.  Off-line coupling of high-resolution capillary electrophoresis to MALDI-TOF and TOF/TOF MS.

Authors:  Tomas Rejtar; Ping Hu; Peter Juhasz; Jennifer M Campbell; Marvin L Vestal; Jan Preisler; Barry L Karger
Journal:  J Proteome Res       Date:  2002 Mar-Apr       Impact factor: 4.466

5.  Proteins of human urine. I. Concentration and analysis by two-dimensional electrophoresis.

Authors:  N G Anderson; N L Anderson; S L Tollaksen
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

6.  Separation, identification of uremic middle molecules, and preliminary study on their toxicity.

Authors:  Guohua Li; Jiegen Chu; Xiaohang Liu; Zhi Yuan
Journal:  Clin Chim Acta       Date:  2004-12       Impact factor: 3.786

Review 7.  Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery.

Authors:  Walter Kolch; Christian Neusüss; Matthias Pelzing; Harald Mischak
Journal:  Mass Spectrom Rev       Date:  2005 Nov-Dec       Impact factor: 10.946

8.  Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

Authors:  Dan Theodorescu; Stefan Wittke; Mark M Ross; Michael Walden; Mark Conaway; Ingo Just; Harald Mischak; Henry F Frierson
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

9.  Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.

Authors:  Stephane Decramer; Stefan Wittke; Harald Mischak; Petra Zürbig; Michael Walden; François Bouissou; Jean-Loup Bascands; Joost P Schanstra
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

10.  Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.

Authors:  Mark A Rogers; Paul Clarke; Jason Noble; Nicholas P Munro; Alan Paul; Peter J Selby; Rosamonde E Banks
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  23 in total

1.  A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy.

Authors:  Wayne G Fisher; Jessica E Lucas; Uzma F Mehdi; Danna W Qunibi; Harold R Garner; Kevin P Rosenblatt; Robert D Toto
Journal:  Proteomics Clin Appl       Date:  2011-12       Impact factor: 3.494

2.  Systematic internal standard selection for capillary liquid chromatography-mass spectrometry time normalization to facilitate serum proteomics.

Authors:  Karen Merrell; Craig D Thulin; M Sean Esplin; Steven W Graves
Journal:  J Biomol Tech       Date:  2008-12

3.  Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Marion Haubitz; David M Good; Alexander Woywodt; Hermann Haller; Harald Rupprecht; Dan Theodorescu; Mohammed Dakna; Joshua J Coon; Harald Mischak
Journal:  Mol Cell Proteomics       Date:  2009-06-28       Impact factor: 5.911

Review 4.  Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.

Authors:  Jing Wu; Yi-ding Chen; Wei Gu
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

5.  Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

Authors:  M Pejchinovski; J Siwy; W Mullen; H Mischak; M A Petri; L C Burkly; R Wei
Journal:  Lupus       Date:  2017-05-05       Impact factor: 2.911

6.  Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Authors:  David M Good; Petra Zürbig; Angel Argilés; Hartwig W Bauer; Georg Behrens; Joshua J Coon; Mohammed Dakna; Stéphane Decramer; Christian Delles; Anna F Dominiczak; Jochen H H Ehrich; Frank Eitner; Danilo Fliser; Moritz Frommberger; Arnold Ganser; Mark A Girolami; Igor Golovko; Wilfried Gwinner; Marion Haubitz; Stefan Herget-Rosenthal; Joachim Jankowski; Holger Jahn; George Jerums; Bruce A Julian; Markus Kellmann; Volker Kliem; Walter Kolch; Andrzej S Krolewski; Mario Luppi; Ziad Massy; Michael Melter; Christian Neusüss; Jan Novak; Karlheinz Peter; Kasper Rossing; Harald Rupprecht; Joost P Schanstra; Eric Schiffer; Jens-Uwe Stolzenburg; Lise Tarnow; Dan Theodorescu; Visith Thongboonkerd; Raymond Vanholder; Eva M Weissinger; Harald Mischak; Philippe Schmitt-Kopplin
Journal:  Mol Cell Proteomics       Date:  2010-07-08       Impact factor: 5.911

7.  Urinary proteomics in diabetes and CKD.

Authors:  Kasper Rossing; Harald Mischak; Mohammed Dakna; Petra Zürbig; Jan Novak; Bruce A Julian; David M Good; Joshua J Coon; Lise Tarnow; Peter Rossing
Journal:  J Am Soc Nephrol       Date:  2008-04-30       Impact factor: 10.121

8.  Discovery and validation of urinary biomarkers for prostate cancer.

Authors:  Dan Theodorescu; Eric Schiffer; Hartwig W Bauer; Friedrich Douwes; Frank Eichhorn; Reinhard Polley; Thomas Schmidt; Wolfgang Schöfer; Petra Zürbig; David M Good; Joshua J Coon; Harald Mischak
Journal:  Proteomics Clin Appl       Date:  2008-03-07       Impact factor: 3.494

9.  Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease.

Authors:  Janet K Snell-Bergeon; David M Maahs; Lorraine G Ogden; Gregory L Kinney; John E Hokanson; Eric Schiffer; Marian Rewers; Harald Mischak
Journal:  Diabetes Technol Ther       Date:  2009-01       Impact factor: 6.118

Review 10.  Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments.

Authors:  Harald Mischak; Joshua J Coon; Jan Novak; Eva M Weissinger; Joost P Schanstra; Anna F Dominiczak
Journal:  Mass Spectrom Rev       Date:  2009 Sep-Oct       Impact factor: 10.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.